Skip to content

Latest News & Upcoming Events

Article: December 2020 | Review of Optometric Business

“Go Big or Go Home” When Investing in Advanced Instrumentation

Due to the impact of AMD on several of his family members, Gary Kirman, OD (of Kirman Eye), has been a staunch advocate of dark adaptation testing as standard of care in eye care practices.

Read Article
Article: December 1, 2020 | Optometric Management

Identify AMD Early to Reduce Risks

For patients who have early AMD and for those who have disease risk factors, patient compliance to prescribed treatments, early detection, and keeping a watchful eye on disease progression is key.

Read Article
Article: October 2020 | Women in Optometry

Big Change is a Small Choice

Just by adding dark adaptation testing to your practice, doctors can do more for patients at risk of developing AMD. By Julie Rodman, OD, MSc, FAAO.

Read Article
Article: September 28, 2020 | NewsWire

AdaptDx Pro by MacuLogix Has Received a Medical Device License by Health Canada

The next generation of dark adaptation testing features a wearable headset and an artificial intelligence-driven onboard technician.

Read Article
Article: September 2, 2020 | Insight Ophthalmic News

AdaptDx Pro Headset Set for Australian Debut

The AdaptDx Pro by MacuLogix launches in Australia, distributed by Optos and pending Therapeutic Goods Administration approval.

Read Article
Article: August 15, 2020 | Review of Optometric Business

Updates Come in Threes

Paul M. Karpecki, OD, dives into the replacement of oft-disliked tests with upgraded options that benefit patients and staff.

Read Article
Article: August 12, 2020 | Review of Optometric Business

AMD: An Evolving Area of Revenue Growth in Optometric Practice

Craig Bowen, OD, (owner of Tualatin Eye Associates) discusses how change is often necessary in order to grow one’s practice.

Read Article
Article: August 11, 2020 | Optometry Times

The Evolving Standard of Care in AMD

Leo Semes, OD, FAAO, Professor of Optometry at the University of Alabama-Birmingham, applies lessons learned from the treatment of glaucoma to the management of age-related macular degeneration.

Read Article
Article: July 9, 2020 | PennLive

‘Most Significant’ Eye Care Innovation…

The AdaptDx Pro may look like a pair of virtual reality goggles, but it’s really a device used for catching the early warning signs of age-related macular degeneration (AMD).

Read Article
Article: July 2020 | Women in Optometry

Turning Losses Into Gains

Leslie Gallagher, OD, FAAO, of Holton, Kansas discusses how a confirmed diagnosis of early or subclinical AMD provides her with the opportunity to discuss optical and nutraceutical needs, which benefit the patient and leads to additional revenue.

Read Article